Victory Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186M Sell
2,179,162
-111,432
-5% -$9.93M 0.12% 204
2025
Q4
$181M Buy
2,290,594
+117,873
+5% +$9.24M 0.1% 189
2025
Q3
$174M Buy
2,172,721
+171,434
+9% +$14.6M 0.1% 193
2025
Q2
$182M Sell
2,001,287
-76,559
-4% -$6.99M 0.12% 194
2025
Q1
$195M Sell
2,077,846
-231,712
-10% -$20.7M 0.2% 117
2024
Q4
$210M Sell
2,309,558
-165,508
-7% -$15.8M 0.21% 109
2024
Q3
$257M Buy
2,475,066
+366,708
+17% +$37.4M 0.25% 92
2024
Q2
$205M Buy
2,108,358
+25,451
+1% +$2.35M 0.21% 113
2024
Q1
$188M Buy
2,082,907
+252,120
+14% +$21.4M 0.18% 123
2023
Q4
$146M Buy
1,830,787
+88,674
+5% +$6.67M 0.15% 146
2023
Q3
$124M Buy
1,742,113
+37,958
+2% +$2.84M 0.14% 154
2023
Q2
$131M Buy
1,704,155
+8,383
+0.5% +$649K 0.14% 152
2023
Q1
$127M Buy
1,695,772
+97,738
+6% +$7.27M 0.14% 160
2022
Q4
$126M Buy
1,598,034
+32,438
+2% +$2.43M 0.14% 160
2022
Q3
$110M Buy
1,565,596
+308,325
+25% +$24.2M 0.13% 201
2022
Q2
$101M Sell
1,257,271
-49,081
-4% -$3.84M 0.11% 229
2022
Q1
$100M Sell
1,306,352
-194,526
-13% -$15.4M 0.1% 266
2021
Q4
$128M Buy
1,500,878
+22,032
+1% +$1.72M 0.12% 204
2021
Q3
$112M Buy
1,478,846
+27,325
+2% +$2.17M 0.11% 230
2021
Q2
$118M Buy
1,451,521
+61,630
+4% +$5.04M 0.11% 223
2021
Q1
$110M Buy
1,389,891
+13,783
+1% +$1.08M 0.11% 230
2020
Q4
$118M Buy
1,376,108
+2,445
+0.2% +$202K 0.13% 200
2020
Q3
$106M Buy
1,373,663
+331,299
+32% +$25.3M 0.14% 198
2020
Q2
$76.4M Sell
1,042,364
-1,492,726
-59% -$106M 0.1% 278
2020
Q1
$168M Buy
2,535,090
+1,297,923
+105% +$91.5M 0.14% 194
2019
Q4
$85.2M Buy
1,237,167
+10,875
+0.9% +$741K 0.1% 278
2019
Q3
$90.1M Buy
1,226,292
+1,028,507
+520% +$74.6M 0.12% 248
2019
Q2
$14.2M Buy
197,785
+106,908
+118% +$7.59M 0.03% 710
2019
Q1
$6.23M Sell
90,877
-224,882
-71% -$14.5M 0.01% 804
2018
Q4
$18.8M Buy
315,759
+15,205
+5% +$951K 0.05% 559
2018
Q3
$20.1M Buy
300,554
+210,412
+233% +$14M 0.04% 606
2018
Q2
$5.84M Buy
90,142
+8,046
+10% +$526K 0.01% 821
2018
Q1
$5.88M Buy
82,096
+23,989
+41% +$1.73M 0.01% 810
2017
Q4
$4.38M Buy
58,107
+457
+0.8% +$33.4K 0.01% 835
2017
Q3
$4.2M Buy
57,650
+1,800
+3% +$130K 0.01% 830
2017
Q2
$4.14M Buy
55,850
+8,917
+19% +$662K 0.01% 832
2017
Q1
$3.44M Buy
46,933
+20,432
+77% +$1.43M 0.01% 862
2016
Q4
$1.73M Buy
26,501
+1,763
+7% +$121K ﹤0.01% 945
2016
Q3
$1.83M Buy
24,738
+13,340
+117% +$986K 0.01% 902
2016
Q2
$834K Sell
11,398
-4,214
-27% -$300K ﹤0.01% 858
2016
Q1
$1.1M Sell
15,612
-15,149
-49% -$1.01M ﹤0.01% 765
2015
Q4
$2.05M Buy
30,761
+12,589
+69% +$837K 0.01% 662
2015
Q3
$1.15M Buy
18,172
+102
+0.6% +$6.66K ﹤0.01% 689
2015
Q2
$1.19M Buy
18,070
+12,455
+222% +$845K ﹤0.01% 708
2015
Q1
$389K Sell
5,615
-11,275
-67% -$779K ﹤0.01% 731
2014
Q4
$1.17M Buy
+16,890
New +$1.14M ﹤0.01% 660
2013
Q4
Sell
-252
Closed -$14K 948
2013
Q3
$14K Buy
+252
New +$14.9K ﹤0.01% 989

Other funds holding CL

Victory Capital Management's CL Position: Q1 2026 in Review

Victory Capital Management reduced its Colgate-Palmolive (CL) stake by 4.9% in Q1 2026, selling an estimated $9.93M and leaving 2,179,162 shares worth $186M. The position accounts for 0.12% of the portfolio, ranked #204.

Victory Capital Management first reported a position in CL in Q3 2013 and has held it in 47 quarters since. The position peaked at $257M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Victory Capital Management held 2,179,162 shares of Colgate-Palmolive worth $186M as of Q1 2026.
  • Victory Capital Management sold 111,432 Colgate-Palmolive shares in Q1 2026, an estimated $9.93M.
  • Colgate-Palmolive made up 0.12% of Victory Capital Management's portfolio in Q1 2026, its #204 holding.
  • Victory Capital Management first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 47 quarters since.
  • Victory Capital Management's Colgate-Palmolive position peaked at $257M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.